Viking Therapeutics (VKTX) Misses Q4 EPS by 3c

Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($0.26), $0.03 worse than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
• Yatsen Holding (YSG) Reports Q2 Loss of $0.16
• J.P. Morgan cuts NIO to Neutral, slashes price target on weak demand outlook